QUOTED. Aug. 8, 2018. Steve Williamson.
Global medtech player Becton Dickinson recently wrapped up an all-cash deal to acquire TVA Medical, which makes an endovascular arteriovenous (AV) fistula creation technology called the everlinQ endoAVF System. See what Steve Williamson, BD's president of Peripheral Intervention, said about it here.
"The addition of TVA Medical allows BD to provide another innovative device to physicians who treat patients suffering from chronic kidney disease requiring hemodialysis. This technology is highly complementary to our Peripheral Intervention offerings, and we will continue to bring new technologies to market that improve our category-leading ESRD portfolio. This is a great example of our continued strategy to use tuck-in acquisitions to advance category leadership." – Steve Williamson president of Peripheral Intervention, Becton Dickinson
Click here for a free trial of Medtech Insight